Content Tagged with: Maurizio Pellecchia

Doubling down on cancer-causing genes

NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
By Iqbal Pittalwala | | Health

A new approach to targeting cancer cells

UC Riverside researchers develop new drugs that target therapeutically relevant protein surfaces
By Iqbal Pittalwala | | Health

UC Riverside researchers find potent chemical agents that can thwart cancer metastasis

Novel agents 135H11 and 135H12 move research closer to drug development
By Iqbal Pittalwala | | Health

New funding to significantly boost cancer, ALS research

UC Riverside’s Maurizio Pellecchia receives grants totaling nearly $2.5 million from National Academy of Sciences, Engineering, and Medicine; and National Institute of Neurological Disorders and Stroke
By Iqbal Pittalwala | | Science / Technology

Researchers use a molecular trojan horse to deliver chemotherapeutic drug to cancer cells

A UCR research team has discovered a way for chemotherapy drug paclitaxel to target migrating cancer cells
By Iqbal Pittalwala | | Health